Delivery Order SPE2DB22D2206-SPE2DB24FGZ01
Award Date 5/2/24
Potential Completion Date 5/3/24
Potential Value $1.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is a delivery order valued at $2,426.43 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product, with a period of performance through October 25, 2024. The award was made by the Defense Logistics Agency (DLA), a defense agency, and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $3,531.46 delivery order is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of August 23, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by DLA Troop Support Medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,541.59 firm fixed-price delivery order is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a type of pharmaceutical product. The contract has an ultimate completion date of July 18, 2024. Amerisourcebergen Drug Corp is a large pharmaceutical distributor that has been awarded numerous government contracts, including Indefinite Delivery Contracts...
- This federal contract award is for $1,031.85 and was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is a delivery order for the procurement of GVOKE HYPOPEN 1-PK 1 MG/0.2 ML 0.2ML, a pharmaceutical product. The contract has an ultimate completion date of August 19, 2024. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including to military treatment facilities, veterans'...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor, to provide GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML medical products. The contract has a ceiling value of $9,718.13 and a performance period through June 17, 2024. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a pharmaceutical product, with a ceiling value of $2,158.78 and an ultimate completion date of August 13, 2024. The contract is a Firm Fixed Price (FFP) Delivery Order, with no set-aside designation. Amerisourcebergen is a prominent supplier of pharmaceutical and...
- The U.S. government has awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML. The contract has a ceiling value of $2,302.82 and a completion date of July 16, 2025. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, which enables AmerisourceBergen to provide a wide range of pharmaceutical...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML medical devices. The contract has a ceiling value of $1,600.08 and a period of performance ending on September 13, 2024. This award is a firm fixed-price delivery order and is not designated as a set-aside. Amerisourcebergen, through its extensive federal contracting...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract has a total ceiling value of $12,376.56 and is a firm fixed price delivery order set to expire on June 11, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division was made by the Defense Logistics Agency (DLA), a defense agency, for the delivery of pharmaceutical products and medical supplies. The $1,731.44 firm-fixed-price delivery order has a completion date of June 27, 2024 and is not associated with a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through...